{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:28:06Z","timestamp":1787772486509,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Myelomatous pleural effusion (MPE) is a very rare condition with a poor prognosis. In our case of multiple myeloma (MM) with early recurrence presenting with a MPE, management of the treatment is discussed together with the case presentation. A 35 year old female patient with a diagnosis of lambda light chain MM presented with complaints of dyspnea and pain in the left shoulder 2 months after autologous transplantation. On physical examination, respiratory sounds were decreased in the lower lobe of the left lung and there was dullness. Pleural effusion and plasmacytoma, more prominent on the left, were detected on chest X ray and thorax computed tomography (CT). The pleural fluid collected during therapeutic thoracentesis was examined by flow cytometry, cytology, and peripheral smear examination and as a result, the patient was considered to have early recurrence after autologous transplantation, DRd chemotherapy was immediately started, and clinical and radiological improvement was observed. Pleural effusion developing in patients with MM should be evaluated in terms of MPE. In the presence of MPE, the duration of response to treatment is short, thus effective and dynamic treatment methods for bridging should be used before referral of the patients to clinical trials and hematopoietic stem cell transplantation.<\/jats:p>","DOI":"10.4103\/ijpm.ijpm_1233_21","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T02:40:09Z","timestamp":1717036809000},"page":"859-861","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Myelomatous pleural effusion developing after autologous stem cell transplantation in a patient with multiple myeloma: A rare case"],"prefix":"10.4103","volume":"66","author":[{"given":"M\u00fczeyyen Aslaner","family":"Ak","sequence":"first","affiliation":[{"name":"Department of Hematology, Faculty of Medicine Zonguldak Bulent Ecevit University, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Barut","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine Zonguldak Bulent Ecevit University, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-019-0660-0","article-title":"Extramedullary multiple myeloma","volume":"34","author":"Bhutani","year":"2020","journal-title":"Leukemia"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.arbres.2018.08.011","article-title":"Extramedullary multiple myeloma with pleural \u0131nvolvement: A rare clinical entity","volume":"55","author":"Velasco-\u00c1lvarez","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0970-2113.201318","article-title":"Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India","volume":"34","author":"Babu","year":"2017","journal-title":"Lung India"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/jmc3428","article-title":"Myelomatous pleural effusion: A rare involvement in myeloma","volume":"11","author":"Alkan","year":"2020","journal-title":"J Med Cases"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1378\/chest.105.2.622","article-title":"Pleural effusion in multiple myeloma","volume":"105","author":"Rodr\u00edguez","year":"1994","journal-title":"Chest"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/dc.23894","article-title":"Cytology and clinical features of myelomatous pleural effusion: three case reports and a review of the literature","volume":"46","author":"Chen","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/10428190500102845","article-title":"Malignant pleural effusion of multiple myeloma: Prognostic factors and outcome","volume":"46","author":"Kamble","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41375-020-0711-6","article-title":"Daratumumab plus lenalidomide and dexamethasone in relapsed\/refractory multiple myeloma: Extended follow-up of POLLUX, a randomized, open-label, phase 3 study","volume":"34","author":"Bahlis","year":"2020","journal-title":"Leukemia"},{"key":"R9-20240829","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.95659","article-title":"Pleural effusion secondary to multiple myeloma. Is daratumumab an effective treatment? A case? report","author":"Plazzo","year":"2021","journal-title":"Multiple Myeloma Ota Fuchs IntechOpen"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_1233_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:49:36Z","timestamp":1787770176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_1233_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_1233_21","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"2021-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}